Literature DB >> 2981743

Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain.

P E Sawchenko, L W Swanson.   

Abstract

The generation of antiserums against a peptide that has met the criteria predicted for corticotropin-releasing factor (CRF) has allowed the immunohistochemical localization of CRF immunoreactive neurons in the rat brain. Although CRF-stained cells have been found to be widely distributed in the central nervous system, attention has focused on neurons in the paraventricular nucleus of the hypothalamus (PVH), which is now acknowledged to be the principal source for delivery of CRF to the hypophyseal portal system. Some 2000 CRF-stained neurons can be counted in the PVH of the colchicine-treated rat, and there is evidence that enkephalin, PHI, and neurotensin coexist with CRF in subsets of parvocellular neurons. Consistent with the established negative feedback effects of adrenal steroids on CRF production and release, adrenalectomy enhances CRF immunoreactivity in parvocellular neurosecretory neurons in the PVH. In addition, immunoreactive vasopressin can be demonstrated in a majority of CRF-stained parvocellular neurons after adrenalectomy, which suggests a form of plasticity that allows for synergy of the two peptides in stimulating adrenocorticotropin secretion. The effects of adrenalectomy appear to be glucocorticoid-dependent, and specific to these peptides and this cell type. A survey of neural inputs to the hypophyseotropic zone of the PVH suggests potential substrates for the control of CRF release and/or synthesis by interoceptive stimuli, by the limbic region, and by a number of cell groups in the basal forebrain. Finally, CRF may also participate in other (nonadenohypophyseal) modes of regulation that are represented in the PVH. Thus, CRF immunoreactivity has been demonstrated in a discrete subset of oxytocinergic magnocellular neurosecretory neurons that project to the posterior pituitary, and in a small fraction of cells in the parvocellular division that project to cell groups in the brain stem and spinal cord that are associated with the control of autonomic functions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981743

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  43 in total

1.  Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus.

Authors:  Y Chen; K L Brunson; M B Müller; W Cariaga; T Z Baram
Journal:  J Comp Neurol       Date:  2000-05-08       Impact factor: 3.215

2.  Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation.

Authors:  Y Zhang; D D'Souza; D K Raap; F Garcia; G Battaglia; N A Muma; L D Van de Kar
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

3.  Demonstration of distinct corticotropin releasing factor--containing neuron populations in the bed nucleus of the stria terminalis. A light and electron microscopic immunocytochemical study in the rat.

Authors:  C F Phelix; W K Paull
Journal:  Histochemistry       Date:  1990

Review 4.  The Physiology of Fear: Reconceptualizing the Role of the Central Amygdala in Fear Learning.

Authors:  Orion P Keifer; Robert C Hurt; Kerry J Ressler; Paul J Marvar
Journal:  Physiology (Bethesda)       Date:  2015-09

Review 5.  Minireview: rapid glucocorticoid signaling via membrane-associated receptors.

Authors:  Jeffrey G Tasker; Shi Di; Renato Malcher-Lopes
Journal:  Endocrinology       Date:  2006-08-31       Impact factor: 4.736

6.  Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors.

Authors:  G Cantarella; L Lempereur; G Lombardo; A Chiarenza; C Pafumi; G Zappalà; R Bernardini
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

7.  Effects of pyrogenic immunomodulators on the release of corticotrophin-releasing factor-41 and prostaglandin E2 from the intact rat hypothalamus in vitro.

Authors:  N G Milton; C H Self; E W Hillhouse
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

Review 8.  Molecular and genetic substrates linking stress and addiction.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Brain Res       Date:  2009-11-10       Impact factor: 3.252

Review 9.  Hypothalamic-brainstem circuits controlling eating.

Authors:  James E Blevins; Denis G Baskin
Journal:  Forum Nutr       Date:  2009-11-27

Review 10.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.